KB

Kevin Barrow

Cyclopharm Limited | Non-Executive Director
Mr Barrow was appointed to the Board on 1 September 2022. He is a member of the Audit and Risk Committee, Remuneration Committee and Board Nomination Committee. Mr Barrow holds a Master of Science (with 1st Class Honours) from Waikato University, New Zealand. He obtained an MBA from the Macquarie Graduate School of Management, Sydney, Australia and is a graduate of the Australian Institute of Company Directors and an Adjunct Fellow at Macquarie University. He brings to the Cyclopharm board more than 20 years of experience in the healthcare industry, which includes numerous governance and senior executive roles.

Company and Role

Company
Title
Tenure
Since
CYC
Cyclopharm Limited
  • Non-Executive Director
1yrs, 8mthSep 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CYC
Cyclopharm Limited
31/12/2311,000N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CYC
Cyclopharm Limited
01/11/23
Buy
1,000$1.960$1,960On-market trade
CYC
Cyclopharm Limited
02/12/22
Buy
10,000$1.380$13,800On-market trade